This clinical trial evaluates whether a home-based aerobic and resistance exercise intervention works to increase physical activity levels in Black, Latinx, or Hispanic patients with breast, colorectal, or prostate cancer receiving chemotherapy. Obesity-related cancers like breast, prostate, and colorectal are more prevalent among minorities and treatments used for these cancers can have side effects on the heart and lungs. Exercise completed during cancer treatment can help maintain or improve physical fitness and functioning and may reduce some of the toxicities or side effects related to treatment.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05327452.
Locations matching your search criteria
United States
Massachusetts
Boston
Dana-Farber Cancer InstituteStatus: Active
Contact: Christina Dieli-Conwright
Phone: 617-582-8321
Brigham and Women's HospitalStatus: Active
Contact: Christina Dieli-Conwright
Phone: 617-582-8321
University of Massachusetts BostonStatus: Active
Contact: Huimin Yan
Phone: 217-621-0832
PRIMARY OBJECTIVE:
I. To determine the effects of a 16-week, technology-based, aerobic and resistance exercise intervention on levels of physical activity participation in Hispanic, Latinx, or Black patients undergoing chemotherapy for breast, prostate, or colorectal cancer.
SECONDARY OBJECTIVE:
I. To determine the effects of a 16-week, technology-based, aerobic and resistance exercise intervention on cardiovascular risk factors.
EXPLORATORY OBJECTIVE:
I. To determine the effects of a 16-week, technology-based, aerobic and resistance exercise intervention on patient-reported outcomes and physical function.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I: Patients perform aerobic and resistance exercise under supervision via Zoom over 45-90 minutes 3 times per week for 16 weeks while wearing a FitBit.
ARM II: Patients attend calls with an exercise trainer once a week over 15 minutes and perform aerobic and resistance exercise without supervision over 45-90 minutes 3 times per week for 16 weeks while wearing a FitBit.
ARM III: Patients perform stretching exercises over 10-15 minutes 3 times a week for 16 weeks.
After completion of study, patients are followed up at weeks 18 and 33.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationDana-Farber Harvard Cancer Center
Principal InvestigatorChristina Dieli-Conwright